PF-Atlas › Clinical Trials › NCT02922751
FibroScan™ in Pediatric Cholestatic Liver Disease
Liver Stiffness Measurement · Not specified
Registry ID
NCT02922751
Phase
Not specified
Status
Completed
Drug / intervention
Liver Stiffness Measurement (LSM)
Sponsor
Arbor Research Collaborative for Health
Start
2016-11-16
Enrollment
552
Locations
13
About this trial
Noninvasive monitoring of liver fibrosis is an unmet need within the clinical management of pediatric chronic liver disease. While liver biopsy is often used in the initial diagnostic evaluation, subsequent biopsies are rarely performed because of inherent invasiveness and risks. This study will evaluate the role of non-invasive FibroScan™ technology to detect and quantify liver fibrosis.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02922751 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.